Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ducts. According to current estimates, between 5 and 16 in every 100,000 people have PSC. The symptoms of PSC ...

Regarding the effect of biliary disease on colitis, there are some open questions following the presented experiments. The study by Bedtke et al does not answer whether it is sclerosing cholangitis ...

Objectives Primary sclerosing cholangitis (PSC) is a rare chronic disease that presents challenges to both patients and clinicians. This study aimed to explore the experiences of patients with PSC ...

Objective Patients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis ... Raw paired-end reads were subjected to the following processes: (1) quality ...

We read with great interest the study by Wunsch et al 1 published in this issue of Polish Archives of Internal Medicine, which validated the prognostic ability of 2 previously ide ...

For primary sclerosing cholangitis there are no established immunomodulatory ... are treated by countering pathogenic immune responses. 1 Clinical Research Center, National Hospital Organization ...

In a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces clinical remission in primary sclerosing cholangitis-associated inflammatory ...

Pliant Therapeutics has pumped the breaks on a mid-stage trial of its lead liver disease drug on the advice of its safety ...

autoimmune hepatitis and sclerosing cholangitis. They all received ld-IL2 (1 million IU/day) for 5 days, followed by fortnightly injections for 6 months. Patients were evaluated by deep ...